Evotec SE (FRA:EVTA) Tax Rate %: 3.11% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:EVTA Evotec SE FRA:EVTA
57 GF Score
Price €1.33
GF Value €2.63
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Evotec SE Tax Rate %?

Evotec SE FRA:EVTA +18.97% 57 Tax Rate % is 3.11% as of Jun. 2026. GuruFocus rates FRA:EVTA with a GF Score™ of 57/100 and a GF Value™ of €2.63 (Possible Value Trap). The stock has 5 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Evotec SE's Tax Expense for the three months ended in Jun. 2026 was €-1.5 Mil. Evotec SE's Pre-Tax Income for the three months ended in Jun. 2026 was €-47.3 Mil. Therefore, Evotec SE's Tax Rate % for the quarter that ended in Jun. 2026 was 3.11%.

Evotec SE Tax Rate % Related Terms

Evotec SE Tax Rate % Historical Data

* Premium members only.

The historical data trend for Evotec SE's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evotec SE Tax Rate % Chart

Evotec SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.75 11.72 39.18 18.92 19.53

Evotec SE Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.14 -0.29 49.78 0.20 3.11
FRA:EVTA
57GF Score
Evotec SE FRA:EVTA
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evotec SE Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Evotec SE's Tax Rate % for the fiscal year that ended in Dec. 2025 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2025 )/Pre-Tax Income (A: Dec. 2025 )
=-24.863/-127.295
=19.53 %

Evotec SE's Tax Rate % for the quarter that ended in Jun. 2026 is calculated as

Tax Rate %=Tax Expense (Q: Jun. 2026 )/Pre-Tax Income (Q: Jun. 2026 )
=-1.471/-47.251
=3.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 3.11% mean?
Evotec SE (FRA:EVTA) has a Tax Rate % of 3.11% as of Jun. 2026.
Is Evotec SE's Tax Rate % too high?
Evotec SE's current Tax Rate % is 3.11%. Overall, Evotec SE has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evotec SE's Tax Rate % compare to ZTS and UTHR?
Evotec SE's Tax Rate % of 3.11% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Drug Manufacturers company?
A good Tax Rate % depends on the Drug Manufacturers industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Evotec SE's current Tax Rate % is 3.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evotec SE stock overvalued right now?
Based on GuruFocus' analysis, Evotec SE (FRA:EVTA) is currently considered Possible Value Trap. The stock's GF Value™ is €2.63, compared to a current price of €1.33 — trading 49.4% below its estimated fair value. The current Tax Rate % is 3.11%. Evotec SE's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For Evotec SE (FRA:EVTA), the current Tax Rate % is 3.11% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evotec SE (FRA:EVTA) Overvalued in 2026?

Based on GuruFocus' analysis, Evotec SE stock appears to be undervalued. The current stock price of €1.33 is trading 49.4% below its estimated GF Value™ of €2.63. GuruFocus considers Evotec SE to be Possible Value Trap.

Key valuation signals for FRA:EVTA:

  • Tax Rate %: 3.11%
  • GF Value™: €2.63 vs. price of €1.33 (49.4% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the FRA:EVTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Evotec SE Business Description

Address Essener Bogen 7, 22419 Hamburg, Hamburg, DEU, 22419
Evotec SE is a German life sciences company that provides drug discovery and development services and participates in partnered research programs. It operates through two main segments: Shared R&D, which includes integrated drug discovery alliances, and Discovery & Preclinical Development, covering preclinical services such as assay development, screening, medicinal chemistry, and biology. The company serves pharmaceutical and biotechnology companies, academic institutions, and foundations, working across therapeutic areas including oncology, central nervous system disorders, metabolic and cardiovascular disease, immunology and inflammation, and infectious diseases. Evotec also invests in and co-develops drug candidates, earning milestones and royalties alongside fee-for-service and full-time-equivalent (FTE) based revenue. It operates research sites and manufacturing facilities across Europe, the United States, and other regions, with a significant share of revenue generated in the United States.
57GF Score

Get the complete analysis for FRA:EVTA

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.33
Price
€2.63
GF Value